オクラホマにおける大腸癌の臨床試験
オクラホマ内の拠点で、大腸癌に関する22件の研究が参加者を募集しています。
オクラホマ内の都市
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Oklahoma, Oklahoma City
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Oklahoma City, Oklahoma City
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Family Communications After Genetic Testing
- Mercy Hospital Oklahoma City, Oklahoma City
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05803382Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT06102902Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Oklahoma, Oklahoma City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Stephenson Cancer Center, Oklahoma City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06696768Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Oklahoma City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832The Vanguard Study: Testing a New Way to Screen for Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898A Study of DM002 in Patients With Advanced Solid Tumors
- University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06751329Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT05691491A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Stephenson Cancer Center, Oklahoma City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
- TSET Health Promotion Research Center, Oklahoma City
被験者募集中
45歳〜75歳 · 全性別 · 2026/07/30更新 · NCT07254910A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- SSM OKC Hightower Clinical, Oklahoma City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT03526835Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Hightower Clinical, Oklahoma City
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06937177Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - OKC, Oklahoma City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/29更新 · NCT07327489KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- OU Stephenson Cancer Center, Oklahoma City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT06026410A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- OU Health Stephenson Cancer Center, Oklahoma City
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/23更新 · NCT06720987Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Mercy Hospital Oklahoma City, Oklahoma City
被験者募集中第3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/03/31更新 · NCT07018869Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Mercy Hospital Oklahoma City, Oklahoma City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
被験者募集中観察研究
18歳以上 · 全性別 · 2025/05/06更新 · NCT05234177ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。